Page 247 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 247

Microbiology  ` microbiology—aNtimicrobials      Microbiology  ` microbiology—aNtimicrobials          SEcTioN ii       203




                  HIV therapy            Antiretroviral therapy (ART): often initiated at the time of HIV diagnosis.
                                         Strongest indication for use with patients presenting with AIDS-defining illness, low CD4+ cell
                                                             3
                                          counts (< 500 cells/mm ), or high viral load. Regimen consists of 3 drugs to prevent resistance:
                                          2 NRTIs and preferably an integrase inhibitor.
                                         All ARTs are active against HIV-1 and HIV-2 with the exception of NNRTIs and enfuvirtide.

                   DrUg                  mecHaNism                                toXicity
                   NRTIs
                   Abacavir (ABC)        Competitively inhibit nucleotide binding to   Bone marrow suppression (can be reversed
                   Didanosine (ddI)       reverse transcriptase and terminate the DNA   with granulocyte colony-stimulating factor
                   Emtricitabine (FTC)    chain (lack a 3′ OH group). Tenofovir is a   [G-CSF] and erythropoietin), peripheral
                   Lamivudine (3TC)       nucleoTide; the others are nucleosides. All   neuropathy, lactic acidosis (nucleosides),
                   Stavudine (d4T)        need to be phosphorylated to be active.   anemia (ZDV), pancreatitis (didanosine).
                   Tenofovir (TDF)       ZDV can be used for general prophylaxis and   Abacavir contraindicated if patient has
                   Zidovudine (ZDV,       during pregnancy to  risk of fetal transmission.  HLA-B*5701 mutation due to  risk of
                     formerly AZT)       Have you dined (vudine) with my nuclear    hypersensitivity.
                                          (nucleosides) family?

                   NNRTIs
                   Delavirdine           Bind to reverse transcriptase at site different   Rash and hepatotoxicity are common to all
                   Efavirenz              from NRTIs. Do not require phosphorylation   NNRTIs. Vivid dreams and CNS symptoms
                   Nevirapine             to be active or compete with nucleotides.   are common with efavirenz.
                   Integrase inhibitors
                   Bictegravir           Inhibits HIV genome integration into host cell    creatine kinase.
                   Dolutegravir           chromosome by reversibly inhibiting HIV
                   Elvitegravir           integrase.
                   Raltegravir
                   Protease inhibitors
                   Atazanavir            Assembly of virions depends on HIV-1 protease   Hyperglycemia, GI intolerance (nausea,
                   Darunavir              (pol gene), which cleaves the polypeptide   diarrhea), lipodystrophy (Cushing-like
                   Fosamprenavir          products of HIV mRNA into their functional   syndrome).
                   Indinavir              parts. Thus, protease inhibitors prevent   Nephropathy, hematuria, thrombocytopenia
                   Lopinavir              maturation of new viruses.                (indinavir).
                   Ritonavir             Ritonavir can “boost” other drug concentrations  Rifampin (potent CYP/UGT inducer) reduces
                   Saquinavir             by inhibiting cytochrome P-450.           protease inhibitor concentrations; use rifabutin
                                         Navir (never) tease a protease.            instead.
                   Entry inhibitors
                   Enfuvirtide           Binds gp41, inhibiting viral entry.      Skin reaction at injection sites.
                                                                                  Enfuvirtide inhibits fusion.
                   Maraviroc             Binds CCR-5 on surface of T cells/monocytes,   Maraviroc inhibits docking.
                                          inhibiting interaction with gp120.























          FAS1_2019_03-Microbiology.indd   203                                                                         11/14/19   12:22 PM
   242   243   244   245   246   247   248   249   250   251   252